COPAN Launches New Website, Offers an Enhanced User Experience and a Modern New Look

May 19, 2015

COPAN Diagnostics, a company committed to new innovations and education in the field of preanalytics, launches a newly redesigned website. The website aims to improve COPAN’s online brand and features various enhancements visitors to the site will enjoy.

Read More
copan fecalswab fecal swab

COPAN is Proud to Announce FDA Clearance for FecalSwab™ to Standardize and Simplify Enteric Culture and Molecular Diagnostics

May 12, 2015

FecalSwab™ simplifies and standardizes fecal sample collection, transport and processing by converting solid or semi-solid fecal specimens into a phase suitable for fully automatic specimen processors, in space saving, instrument ready tubes. FecalSwab™ provides a compact and neat alternative to traditional large, bulky transport containers, which collect a quantity far greater than needed for culture or molecular testing.

Read More
COPAN flocked swabs shaped in a heart love

Two New US Patents Protect COPAN Invention of Flocked Swabs

April 23, 2015

Notably these two new US patents, US 8,979,784 and US 9,011,358, have a broad scope of protection for the flocked swab device, in addition to the method of use of such device previously covered by the first two US patents. COPAN is in a strong position to legally stop any infringing activity, such as manufacturing, promoting and selling, including exporting from the US to other countries, flocked swabs covered by the patent claims.

Read More
VI-PAK Barrier Outer Foil Pack for ESwab™

COPAN Announces New VI-PAK Barrier Outer Foil Pack for ESwab™

October 14, 2014

The distinctive VI-PAK metallic appearance is due to the high-tech composite of metallic foil and barrier plastic film proven to provide the ultimate product protection and shelf life stability. It creates a closed system for maintaining optimum performance of the medium over its long shelf life.

Read More
daniele triva in copan office on phone

COPAN Group Announces the Untimely Death of Its Beloved CEO and General Manager, Daniele Triva

September 2, 2014

COPAN Group announces with great sadness that, on July 30th, 2014, its beloved, charismatic and eclectic leader, Daniele Triva passed away at his home in Italy, after a seven-month battle with Esophageal Gastric cancer. Daniele was 54 years old and…

Read More

Beckman Coulter Diagnostics and COPAN Announce Expansion of Distribution Agreement for Automated Sample Processing Systems and Digital Microbiology

August 10, 2014

Beckman Coulter Diagnostics and COPAN Group have entered into an amendment to their distribution agreement that expands their relationship into new products and geographic territories. Additional products include COPAN’s WASPLab automated, front-end robotic specimen processing, full lab automation and digital microbiology system.

Read More

UTM™ and ESwab™ Are Ideal Collection and Transport Systems for Diagnosis of Patients with Whooping Cough

July 9, 2014

UTM™ is a cross-platform medium proven to be good for viruses, as well as Bordetella. COPAN’s complete array of products have a proven track record, through numerous clinical and scientific publications, demonstrating their high quality and reliability. COPAN has experience responding to epidemics, like Whooping Cough, by producing products for specimen collection and transport in a timely manner.

Read More
tech using copan wasplab for microbiology laboratory automation


May 19, 2014

OPAN and MetaSystems GmbH are pleased to announce they have signed a global and exclusive agreement for the integration of automatic microscopy slide scanning system, provided by MetaSystems, with WASPLab™.

Read More
tech using copan wasp for microbiology laboratory automation

COPAN Announces WASP® Distribution Agreement with Thermo Fisher Scientific Inc. in the United States

February 28, 2014

COPAN Diagnostics, Inc. announced today a distribution agreement for COPAN WASP®: Walk-Away Specimen Processor with Thermo Fisher Scientific Inc. in the United States.

Read More
COPAN Flocked Swabs and UTM™ Viral Transport Media Available in Response to pH1N1 Upsurge

COPAN Flocked Swabs and UTM™ Viral Transport Media Available in Response to pH1N1 Upsurge

January 10, 2014

During the 2009 H1N1 outbreak, COPAN invested tremendously in production capacity to meet the global demand, so we are more than prepared to handle the increased demand we are seeing now” says Norman Sharples, CEO of COPAN Diagnostics, Inc. “As the leader in collection and transport systems, we have the infrastructure needed to meet the demand in a timely manner.

Read More